Feladilimab

Feladilimab Uses, Dosage, Side Effects, Food Interaction and all others data.

Feladilimab is under investigation in clinical trial NCT04128696 (Study of GSK3359609 and Pembrolizumab in Programmed Death Receptor 1-ligand 1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma).

Trade Name Feladilimab
Generic Feladilimab
Feladilimab Other Names Feladilimab
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Feladilimab
Feladilimab

Innovators Monograph

You find simplified version here Feladilimab


*** Taking medicines without doctor's advice can cause long-term problems.
Share